Beyond Air announces termination of agreement to sell its NeuroNOS subsidiary to XTL Biopharmaceuticals ($0.86, 0.00)
XTL Biopharmaceuticals Ltd. (XTLB) to acquire 85% of NeuroNOS Ltd., a subsidiary of Beyond Air ($0.88, 0.00)
Powered by FactSet Research Systems Inc.